Clinical Trials in Plauen, Germany
4 recruiting
Showing 1–6 of 6 trials
Recruiting
A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
Breast Neoplasms
Novartis Pharmaceuticals3,250 enrolled267 locationsNCT06830720
Recruiting
Non-interventional Study to Collect Real-world Clinical and Patient-reported Outcomes in Ovarian Cancer
Ovarian Cancer
AstraZeneca750 enrolled93 locationsNCT04830709
Recruiting
NIS to Examine the Effectiveness and Safety of Durvalumab and Olaparib in Patients With Endometrial Cancer (DUOLife)
Endometrial Cancer
AstraZeneca150 enrolled33 locationsNCT06890273
Recruiting
A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
Moderate to Severe Rheumatoid Arthritis
AbbVie678 enrolled53 locationsNCT06712628
Recruiting
Phase 4
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
Hormone Receptor-positive Metastatic Breast CancerHER2-negative Metastatic Breast Cancer
Prof. Wolfgang Janni300 enrolled54 locationsNCT05362760
Recruiting
The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
Heart FailureAtrial FibrillationCoronary Artery Disease
Helios Health Institute GmbH24,000 enrolled10 locationsNCT04844944